| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.46e-07 | 11 | 116 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 2.64e-05 | 149 | 116 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.43e-05 | 32 | 116 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural molecule activity | FRAS1 H2AZ2 ANK1 POTEF NUP88 ADD1 PGM5 KRT73 POTEE HMCN1 H2AZ1 MACF1 POTEI POTEJ MUC5AC RPL4 | 5.72e-05 | 891 | 116 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 6.64e-05 | 14 | 116 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.02e-04 | 42 | 116 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.12e-04 | 130 | 116 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.28e-04 | 210 | 116 | 7 | GO:0019903 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.11e-04 | 23 | 116 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 5.24e-04 | 173 | 116 | 6 | GO:0070851 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 6.14e-04 | 324 | 116 | 8 | GO:0005126 | |
| GeneOntologyMolecularFunction | filamin binding | 6.25e-04 | 29 | 116 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 6.25e-04 | 29 | 116 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | phosphatase binding | 8.94e-04 | 264 | 116 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.00e-03 | 34 | 116 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | kinase binding | RASGRF1 PSG3 PSG4 PSG7 POTEF SHC1 CIT OPA1 POTEE ANGPT4 PSG8 DUSP10 POTEI POTEJ | 1.48e-03 | 969 | 116 | 14 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | RASGRF1 PSG3 PSG4 PSG7 POTEF SHC1 CIT POTEE ANGPT4 PSG8 DUSP10 POTEI POTEJ | 1.68e-03 | 873 | 116 | 13 | GO:0019901 |
| GeneOntologyBiologicalProcess | neuron projection development | PLXNA3 DIP2B RASGRF1 POTEF SHC1 BBS1 VPS54 SHOC2 CIT OPA1 POTEE FBXO38 STK11 ARSB TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 2.47e-06 | 1285 | 116 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 9.25e-06 | 24 | 116 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PLXNA3 DIP2B POTEF VPS54 CIT OPA1 POTEE STK11 TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 1.08e-05 | 802 | 116 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 DIP2B POTEF VPS54 CIT OPA1 POTEE STK11 TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 1.40e-05 | 819 | 116 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 DIP2B POTEF VPS54 CIT OPA1 POTEE STK11 TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 1.56e-05 | 826 | 116 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron development | PLXNA3 DIP2B RASGRF1 POTEF SHC1 BBS1 VPS54 SHOC2 CIT OPA1 POTEE FBXO38 STK11 ARSB TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 1.94e-05 | 1463 | 116 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.02e-05 | 29 | 116 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.66e-05 | 31 | 116 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.66e-05 | 31 | 116 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide catabolic process | 2.77e-05 | 11 | 116 | 3 | GO:0009222 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLXNA3 DIP2B POTEF BBS1 VPS54 CIT OPA1 ADD1 POTEE STK11 FAT1 TET1 VPS13A MACF1 KDR POTEI POTEJ RPL4 SOS1 | 3.64e-05 | 1194 | 116 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 3.87e-05 | 34 | 116 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 4.35e-05 | 35 | 116 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | PSG3 PSG4 SHC1 SHOC2 OPA1 JAK3 STK11 FAT1 ABCC8 H2AZ1 PSG8 SOS1 | 4.46e-05 | 530 | 116 | 12 | GO:0043434 |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 5.90e-05 | 381 | 116 | 10 | GO:0071375 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 6.03e-05 | 14 | 116 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.51e-05 | 15 | 116 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.51e-05 | 15 | 116 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.51e-05 | 15 | 116 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.51e-05 | 15 | 116 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 DIP2B POTEF BBS1 CIT OPA1 POTEE STK11 TET1 MACF1 POTEI POTEJ RPL4 SOS1 | 7.97e-05 | 748 | 116 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 9.20e-05 | 16 | 116 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.11e-04 | 17 | 116 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.11e-04 | 17 | 116 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.11e-04 | 17 | 116 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 1.15e-04 | 334 | 116 | 9 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 1.15e-04 | 334 | 116 | 9 | GO:0001894 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 1.29e-04 | 46 | 116 | 4 | GO:0072529 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.33e-04 | 18 | 116 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.41e-04 | 47 | 116 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | hemopoiesis | ITCH ANK1 PSG3 PSG4 ARL11 C17orf99 VPS54 OPA1 ADD1 JAK3 STK11 VPS13A KDR PSG8 ALAS2 DUSP10 SOS1 GP5 | 1.61e-04 | 1223 | 116 | 18 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.66e-04 | 49 | 116 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 1.74e-04 | 353 | 116 | 9 | GO:0010721 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.79e-04 | 50 | 116 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.84e-04 | 20 | 116 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.14e-04 | 21 | 116 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.14e-04 | 21 | 116 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.14e-04 | 21 | 116 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | response to hormone | PSG3 PSG4 SHC1 VPS54 SHOC2 OPA1 USP26 JAK3 STK11 FAT1 ARSB ABCC8 H2AZ1 PSG8 ABCC2 SOS1 | 2.40e-04 | 1042 | 116 | 16 | GO:0009725 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | ANK1 PSG3 PSG4 BBS1 VPS54 ADD1 JAK3 STK11 ABCC8 VPS13A KDR PSG8 ALAS2 PLCL1 MUC5AC SOS1 | 2.43e-04 | 1043 | 116 | 16 | GO:0048871 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.47e-04 | 22 | 116 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.78e-04 | 56 | 116 | 4 | GO:0002418 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide catabolic process | 2.83e-04 | 23 | 116 | 3 | GO:0006244 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 2.83e-04 | 23 | 116 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.83e-04 | 23 | 116 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.22e-04 | 24 | 116 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.22e-04 | 24 | 116 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.64e-04 | 25 | 116 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.64e-04 | 25 | 116 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 3.64e-04 | 25 | 116 | 3 | GO:0046579 | |
| GeneOntologyBiologicalProcess | regulation of cell development | PLXNA3 DIP2B PSG3 PSG4 CIT OPA1 ADD1 JAK3 STK11 ABCC8 MACF1 KDR PSG8 DUSP10 RPL4 SOS1 | 4.16e-04 | 1095 | 116 | 16 | GO:0060284 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | TRPM4 NRIP1 PSG3 PSG4 SHC1 HTR3C VPS54 PPBP SHOC2 OPA1 ADD1 JAK3 FAT1 ABCC8 TET1 H2AZ1 PSG8 CD180 SOS1 | 4.53e-04 | 1450 | 116 | 19 | GO:1901701 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 4.59e-04 | 27 | 116 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.12e-04 | 28 | 116 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 5.23e-04 | 66 | 116 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.54e-04 | 67 | 116 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 5.66e-04 | 119 | 116 | 5 | GO:0006892 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 6.19e-04 | 69 | 116 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | CMP catabolic process | 6.46e-04 | 7 | 116 | 2 | GO:0006248 | |
| GeneOntologyBiologicalProcess | dTMP catabolic process | 6.46e-04 | 7 | 116 | 2 | GO:0046074 | |
| GeneOntologyBiologicalProcess | dUMP catabolic process | 6.46e-04 | 7 | 116 | 2 | GO:0046079 | |
| GeneOntologyBiologicalProcess | UMP catabolic process | 6.46e-04 | 7 | 116 | 2 | GO:0046050 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 6.54e-04 | 70 | 116 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 6.62e-04 | 515 | 116 | 10 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 6.90e-04 | 71 | 116 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 6.90e-04 | 71 | 116 | 4 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 7.02e-04 | 519 | 116 | 10 | GO:0001558 | |
| GeneOntologyBiologicalProcess | response to insulin | 7.08e-04 | 342 | 116 | 8 | GO:0032868 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 7.28e-04 | 72 | 116 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 7.35e-04 | 344 | 116 | 8 | GO:0010632 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 7.35e-04 | 344 | 116 | 8 | GO:0003018 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 7.55e-04 | 432 | 116 | 9 | GO:0010631 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 7.63e-04 | 32 | 116 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 7.63e-04 | 32 | 116 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 7.63e-04 | 32 | 116 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | epithelium migration | 7.93e-04 | 435 | 116 | 9 | GO:0090132 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | PSG3 PSG4 SHC1 VPS54 SHOC2 OPA1 USP26 JAK3 FAT1 H2AZ1 PSG8 SOS1 | 8.11e-04 | 727 | 116 | 12 | GO:0032870 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 8.36e-04 | 33 | 116 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 8.36e-04 | 33 | 116 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | dCMP catabolic process | 8.59e-04 | 8 | 116 | 2 | GO:0006249 | |
| GeneOntologyBiologicalProcess | dUMP metabolic process | 8.59e-04 | 8 | 116 | 2 | GO:0046078 | |
| GeneOntologyBiologicalProcess | dCMP metabolic process | 8.59e-04 | 8 | 116 | 2 | GO:0046063 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate catabolic process | 8.59e-04 | 8 | 116 | 2 | GO:0009175 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 8.63e-04 | 271 | 116 | 7 | GO:0032869 | |
| GeneOntologyBiologicalProcess | tissue migration | 8.73e-04 | 441 | 116 | 9 | GO:0090130 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 9.13e-04 | 34 | 116 | 3 | GO:0009218 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 9.13e-04 | 34 | 116 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 9.95e-04 | 35 | 116 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | TRPM4 PSG3 PSG4 SHC1 HTR3C SHOC2 OPA1 JAK3 FAT1 H2AZ1 PSG8 SOS1 | 1.09e-03 | 752 | 116 | 12 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 1.14e-03 | 458 | 116 | 9 | GO:0050863 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.14e-03 | 139 | 116 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | PLXNA3 DIP2B PSG3 PSG4 SHC1 CIT OPA1 ADD1 STK11 ABCC8 ANGPT4 MACF1 KDR PSG8 RPL4 | 1.17e-03 | 1090 | 116 | 15 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.27e-03 | 38 | 116 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.35e-03 | 566 | 116 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.37e-03 | 39 | 116 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | positive regulation of rRNA processing | 1.37e-03 | 10 | 116 | 2 | GO:2000234 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate catabolic process | 1.37e-03 | 10 | 116 | 2 | GO:0009131 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate catabolic process | 1.37e-03 | 10 | 116 | 2 | GO:0009178 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.41e-03 | 86 | 116 | 4 | GO:0042058 | |
| GeneOntologyBiologicalProcess | regulation of growth | PLXNA3 DIP2B ITCH PSG3 JADE3 PSG4 VPS54 STK11 MACF1 PSG8 DUSP10 RPL4 | 1.43e-03 | 777 | 116 | 12 | GO:0040008 |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 2.77e-05 | 32 | 115 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 2.77e-05 | 32 | 115 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 8.62e-05 | 16 | 115 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.09e-04 | 45 | 115 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.72e-04 | 94 | 115 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 2.75e-04 | 104 | 115 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.42e-04 | 109 | 115 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | anchoring junction | PSG3 PSG4 SHC1 ADD1 PGM5 SLC3A2 FAT1 HMCN1 LPXN KDR PSG8 CGNL1 ABCC2 RPL4 | 9.42e-04 | 976 | 115 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | adherens junction | 1.14e-03 | 212 | 115 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.31e-03 | 576 | 115 | 10 | GO:0015629 | |
| Domain | Ankyrin_rpt | TRPM4 SLF1 ANK1 POTEF POTEG ANKRD6 POTEE POTEM POTEI POTEA POTEJ | 7.19e-07 | 262 | 116 | 11 | IPR002110 |
| Domain | Ank_2 | 9.35e-07 | 215 | 116 | 10 | PF12796 | |
| Domain | Ank | 1.59e-06 | 228 | 116 | 10 | PF00023 | |
| Domain | Actin_CS | 2.43e-06 | 16 | 116 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 3.16e-06 | 17 | 116 | 4 | PS00432 | |
| Domain | - | 3.38e-06 | 248 | 116 | 10 | 1.25.40.20 | |
| Domain | ANK | 3.76e-06 | 251 | 116 | 10 | SM00248 | |
| Domain | ANK_REPEAT | 4.04e-06 | 253 | 116 | 10 | PS50088 | |
| Domain | Actin/actin-like_CS | 4.04e-06 | 18 | 116 | 4 | IPR020902 | |
| Domain | Ankyrin_rpt-contain_dom | 4.18e-06 | 254 | 116 | 10 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.18e-06 | 254 | 116 | 10 | PS50297 | |
| Domain | ACTINS_ACT_LIKE | 5.09e-06 | 19 | 116 | 4 | PS01132 | |
| Domain | CCDC74 | 3.82e-05 | 2 | 116 | 2 | IPR033226 | |
| Domain | CCDC74_C | 3.82e-05 | 2 | 116 | 2 | IPR029422 | |
| Domain | CCDC74_C | 3.82e-05 | 2 | 116 | 2 | PF14917 | |
| Domain | Actin | 3.90e-05 | 31 | 116 | 4 | IPR004000 | |
| Domain | Actin | 3.90e-05 | 31 | 116 | 4 | PF00022 | |
| Domain | ACTIN | 3.90e-05 | 31 | 116 | 4 | SM00268 | |
| Domain | IGc2 | 6.66e-04 | 235 | 116 | 7 | SM00408 | |
| Domain | Ig_sub2 | 6.66e-04 | 235 | 116 | 7 | IPR003598 | |
| Domain | Ig_2 | 1.11e-03 | 73 | 116 | 4 | PF13895 | |
| Domain | ig | 1.20e-03 | 190 | 116 | 6 | PF00047 | |
| Domain | Immunoglobulin | 1.20e-03 | 190 | 116 | 6 | IPR013151 | |
| Domain | Calx_beta | 1.34e-03 | 9 | 116 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.34e-03 | 9 | 116 | 2 | PF03160 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.99e-05 | 194 | 84 | 8 | M16312 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 4.28e-05 | 158 | 84 | 7 | MM14812 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 7.09e-05 | 14 | 84 | 3 | M27858 | |
| Pathway | PID_TCPTP_PATHWAY | 1.10e-04 | 42 | 84 | 4 | M91 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.28e-04 | 188 | 84 | 7 | MM15828 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.31e-04 | 17 | 84 | 3 | MM14836 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.56e-04 | 18 | 84 | 3 | M11932 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 2.51e-04 | 21 | 84 | 3 | M5489 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 2.90e-04 | 22 | 84 | 3 | M7747 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 2.90e-04 | 22 | 84 | 3 | MM1415 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 3.32e-04 | 23 | 84 | 3 | MM1411 | |
| Pathway | PID_SHP2_PATHWAY | 3.64e-04 | 57 | 84 | 4 | M100 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 5.18e-04 | 6 | 84 | 2 | MM14887 | |
| Pathway | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | 5.38e-04 | 27 | 84 | 3 | M1718 | |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 5.38e-04 | 27 | 84 | 3 | M921 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 6.55e-12 | 15 | 118 | 6 | 16824795 | |
| Pubmed | 5.14e-11 | 9 | 118 | 5 | 16364570 | ||
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 3.81e-08 | 3 | 118 | 3 | 17101985 | |
| Pubmed | Activation of CEA-CAM-1-mediated cell adhesion via CD98: involvement of PKCdelta. | 1.67e-07 | 15 | 118 | 4 | 14527684 | |
| Pubmed | CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. | 1.67e-07 | 15 | 118 | 4 | 15467833 | |
| Pubmed | Shc and CEACAM1 interact to regulate the mitogenic action of insulin. | 2.22e-07 | 16 | 118 | 4 | 11694516 | |
| Pubmed | 2.90e-07 | 17 | 118 | 4 | 7851895 | ||
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 10319320 | ||
| Pubmed | PLXNA3 H2AZ2 POTEF SLC3A2 KRT73 POTEE STK11 C2CD3 WDR75 VPS13A H2AZ1 MACF1 KDR ALAS2 MPHOSPH10 ABCC2 POTEI POTEJ RPL4 | 4.01e-07 | 1442 | 118 | 19 | 35575683 | |
| Pubmed | 1.32e-06 | 7 | 118 | 3 | 15276201 | ||
| Pubmed | 1.49e-06 | 163 | 118 | 7 | 24316575 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.28e-06 | 271 | 118 | 8 | 32433965 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PLXNA3 TRPM4 FRAS1 RTTN KIAA0319L SHC1 KDM3B CIT DUS1L PPP1R26 JAK3 FAT1 C2CD3 PSME4 ZNF426 | 5.27e-06 | 1105 | 118 | 15 | 35748872 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.06e-05 | 13 | 118 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.06e-05 | 13 | 118 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.06e-05 | 13 | 118 | 3 | 16638824 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 20044046 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 32150576 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 6265583 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.06e-05 | 13 | 118 | 3 | 12832451 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.06e-05 | 13 | 118 | 3 | 21670291 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 22162753 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 2702644 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 8380065 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 1279194 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 25724769 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.06e-05 | 13 | 118 | 3 | 22092845 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 11801635 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.06e-05 | 13 | 118 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.06e-05 | 13 | 118 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.06e-05 | 13 | 118 | 3 | 23800882 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 19285068 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 21760897 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.06e-05 | 13 | 118 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.06e-05 | 13 | 118 | 3 | 39168268 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 8402684 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 16619040 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.06e-05 | 13 | 118 | 3 | 8209741 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.06e-05 | 13 | 118 | 3 | 21949477 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 26219866 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 2133556 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 32521208 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 19406938 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.06e-05 | 13 | 118 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.06e-05 | 13 | 118 | 3 | 19358828 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 16680193 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.06e-05 | 13 | 118 | 3 | 34058224 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 10964771 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 32169849 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.06e-05 | 13 | 118 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.06e-05 | 13 | 118 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.06e-05 | 13 | 118 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.06e-05 | 13 | 118 | 3 | 23935487 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 15331748 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.06e-05 | 13 | 118 | 3 | 22406619 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.06e-05 | 13 | 118 | 3 | 25972571 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 19008452 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.06e-05 | 13 | 118 | 3 | 15220458 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 18843289 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 15207636 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 21081647 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 11133662 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 11483763 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 2164599 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 29396368 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 18003729 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.06e-05 | 13 | 118 | 3 | 33352461 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 38381498 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 20739537 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.06e-05 | 13 | 118 | 3 | 27695943 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 20404914 | ||
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.06e-05 | 13 | 118 | 3 | 32027621 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.06e-05 | 13 | 118 | 3 | 27777319 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 18848945 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 35474489 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8631299 | ||
| Pubmed | The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia. | 1.14e-05 | 2 | 118 | 2 | 27246103 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30482841 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.14e-05 | 2 | 118 | 2 | 19669888 | |
| Pubmed | Expression of the pregnancy-specific beta 1-glycoprotein genes in human testis. | 1.14e-05 | 2 | 118 | 2 | 2302228 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34309670 | ||
| Pubmed | Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts. | 1.14e-05 | 2 | 118 | 2 | 26172285 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33562813 | ||
| Interaction | PSG4 interactions | 1.05e-05 | 8 | 117 | 3 | int:PSG4 | |
| Interaction | POTEJ interactions | 1.26e-05 | 52 | 117 | 5 | int:POTEJ | |
| Cytoband | 2q21.1 | 9.20e-09 | 58 | 118 | 6 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 2.79e-06 | 151 | 118 | 6 | chr2q21 | |
| Cytoband | 8p11.1 | 3.92e-05 | 4 | 118 | 2 | 8p11.1 | |
| Cytoband | 19q13.2 | 8.78e-04 | 164 | 118 | 4 | 19q13.2 | |
| Cytoband | 16q22.2 | 1.46e-03 | 22 | 118 | 2 | 16q22.2 | |
| Cytoband | 12q24 | 1.89e-03 | 25 | 118 | 2 | 12q24 | |
| Cytoband | 2q33 | 2.54e-03 | 29 | 118 | 2 | 2q33 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.26e-14 | 13 | 80 | 7 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.11e-07 | 242 | 80 | 10 | 403 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.15e-07 | 11 | 80 | 4 | 1315 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.25e-03 | 181 | 80 | 5 | 694 | |
| GeneFamily | ATP binding cassette subfamily C | 1.46e-03 | 13 | 80 | 2 | 807 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | ADAM23 CNOT10 POTEF POTEG ANKRD6 SHOC2 SLC3A2 YARS2 CDC7 POTEE PSME4 POTEM POTEI POTEA POTEJ CD180 | 7.59e-09 | 584 | 117 | 16 | MM1080 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-08 | 184 | 118 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-08 | 184 | 118 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-08 | 184 | 118 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.09e-07 | 63 | 118 | 5 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-06 | 136 | 118 | 6 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-06 | 136 | 118 | 6 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 3.37e-06 | 153 | 118 | 6 | 654265f3c14344071b2af7ca05cbdbb17ce2c5d3 | |
| ToppCell | Enthrocyte|World / shred on cell class and cell subclass (v4) | 3.37e-06 | 153 | 118 | 6 | 105b91f5277d145f7717307d7eb9b7d8e8e23576 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.19e-06 | 90 | 118 | 5 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.03e-05 | 186 | 118 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-05 | 186 | 118 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.10e-05 | 188 | 118 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 195 | 118 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 199 | 118 | 6 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.52e-05 | 199 | 118 | 6 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Dpy19l1_(Neuron.Gad1Gad2.Synpr-Dpy19l1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.61e-05 | 70 | 118 | 4 | 1d06fd0e20f4b3ea71a83c87736236f5c8d39f65 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Dpy19l1_(Neuron.Gad1Gad2.Synpr-Dpy19l1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.61e-05 | 70 | 118 | 4 | e446f52534a1e8291dbb0973c6bc5094a3ebc96b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 141 | 118 | 5 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 141 | 118 | 5 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 145 | 118 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| Disease | cD177 antigen measurement | 3.54e-05 | 18 | 106 | 3 | EFO_0021866 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 7.63e-05 | 4 | 106 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | visual epilepsy (implicated_via_orthology) | 2.49e-04 | 34 | 106 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 3.53e-04 | 8 | 106 | 2 | C0266294 | |
| Disease | Turner Syndrome, Male | 6.88e-04 | 11 | 106 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 6.88e-04 | 11 | 106 | 2 | C1527404 | |
| Disease | Noonan Syndrome 1 | 6.88e-04 | 11 | 106 | 2 | C4551602 | |
| Disease | chronic lymphocytic leukemia | 9.10e-04 | 119 | 106 | 4 | EFO_0000095 | |
| Disease | rhinitis (biomarker_via_orthology) | 9.72e-04 | 13 | 106 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | 9.80e-04 | 702 | 106 | 9 | C0009402 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.09e-03 | 56 | 106 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.20e-03 | 58 | 106 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | RASopathy | 1.30e-03 | 15 | 106 | 2 | cv:C5555857 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.62e-03 | 139 | 106 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | ascending aortic diameter | 1.66e-03 | 140 | 106 | 4 | EFO_0021787 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 2.10e-03 | 19 | 106 | 2 | C3501846 | |
| Disease | Costello syndrome (disorder) | 2.10e-03 | 19 | 106 | 2 | C0587248 | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.10e-03 | 19 | 106 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 2.10e-03 | 19 | 106 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 2.10e-03 | 19 | 106 | 2 | C1275081 | |
| Disease | response to methotrexate, neurotoxicity | 2.10e-03 | 19 | 106 | 2 | EFO_0011057, GO_0031427 | |
| Disease | haptoglobin measurement | 2.57e-03 | 21 | 106 | 2 | EFO_0004640 | |
| Disease | Primary microcephaly | 2.82e-03 | 22 | 106 | 2 | C0431350 | |
| Disease | LEOPARD Syndrome | 2.82e-03 | 22 | 106 | 2 | C0175704 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 3.08e-03 | 23 | 106 | 2 | EFO_0006919, GO_1903493 | |
| Disease | Noonan Syndrome | 3.35e-03 | 24 | 106 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGHTKNLLRPTKLNL | 766 | Q9BXU7 | |
| SHGLLVQQALPKAKL | 156 | Q9H0P0 | |
| SGVKHKGLIEIPNLS | 96 | Q719I0 | |
| VLGKHPLLSGGTKRN | 521 | A8K979 | |
| KSTGRPHIIQKTLAG | 241 | O75077 | |
| LLDHGAPIQAKTKNG | 291 | P16157 | |
| IPHIHKSLIGKKGQQ | 111 | Q71UI9 | |
| LLTVHGRTKEQKGPL | 171 | Q6P1R4 | |
| QKGNKGLGLTLTHLP | 366 | Q8WXA8 | |
| LNGPKSLKHLFLIQT | 121 | Q99467 | |
| LLHNSKLDKVPGVQG | 211 | Q96AQ1 | |
| LLHNSKLDKVPGVQG | 211 | Q96LY2 | |
| LSGISLQKKLQHVPG | 251 | Q5RIA9 | |
| LNVLKNSLTHVPGIG | 1616 | O14578 | |
| NSPVQLAGLKLLGHL | 406 | Q6P1M9 | |
| KGILPTTIDKKHQNG | 261 | Q9ULK2 | |
| NKGHLPVVQILLKAG | 51 | Q9Y2G4 | |
| KGIGTLHLKPTANQK | 376 | Q9UKX7 | |
| IVLSTLPNKHGILQK | 541 | Q9ULI1 | |
| KGLPHGNVSARKVLL | 641 | P52333 | |
| RHSGLIGPLKENTIK | 981 | O75747 | |
| HAIKGLLTGPSQLKI | 211 | Q15124 | |
| KLKGHQLVETLPTVG | 31 | Q969Q4 | |
| HFQIGPLGEISLKKQ | 2126 | Q14517 | |
| ESKNKHGLTPLLLGV | 266 | A5A3E0 | |
| KSNIGHLCKLGPQLQ | 451 | M0R2J8 | |
| KHGNLEQISIKGPIR | 2131 | Q86XX4 | |
| SKLKLPNNGRIHVGK | 111 | Q9BZ81 | |
| PGGIHQVTINKSLLA | 101 | Q86Y46 | |
| KKTGSRPVVLLQHGL | 86 | Q5VYY2 | |
| GKHSQILKLSKLTPG | 361 | Q8IZA0 | |
| LSGISLQKKLQHVPG | 251 | Q8IUF1 | |
| LSGISLQKKLQHVPG | 251 | Q9BRT8 | |
| PLVLKGGLSSFKQNH | 266 | Q9Y6W6 | |
| GSHVVLKGKNLIPAA | 1141 | P51805 | |
| HALGPVKLSQKELLG | 381 | Q14807 | |
| TLLHSPSQVGLLKNG | 1631 | Q5H8C1 | |
| KTPLGGIHISQTKQL | 906 | Q9P265 | |
| QGQPVLVSGVHKKLK | 1411 | Q7LBC6 | |
| TVLQLLLGNPNKGKS | 711 | P48552 | |
| KILENGRIHGSPLQK | 51 | O00566 | |
| QKPIAGKVIHALGQS | 156 | O60711 | |
| GKHIFNKVLGPNGLL | 796 | Q92887 | |
| PNGLLKGKTRLLVTH | 806 | Q92887 | |
| QLTKGSVLVNGHPVL | 146 | P98088 | |
| NVSKLNILKLAPGGH | 231 | P36578 | |
| LLQHKSPSALGKGVL | 166 | Q9UPP2 | |
| RGPTSLLGKVVKTHQ | 16 | P22557 | |
| SIINPHNLKGKSLGQ | 2871 | Q9UPN3 | |
| KGGPQSLVILLNKST | 3716 | Q96RW7 | |
| ESKNKHGLTPLLLGV | 266 | Q6S8J3 | |
| SSGIKGSLPLQKLHL | 21 | O60313 | |
| PIGAKIQTLHLVGVN | 186 | Q6PIJ6 | |
| KSHDLKPNGGNILVT | 716 | Q96J02 | |
| AKNRKGIAIIIHGTP | 2031 | Q4G0P3 | |
| GHSEKLPLILKNNGV | 3501 | Q4G0P3 | |
| PITNSLIGKDGQVHL | 156 | Q6UX52 | |
| LGIILAKAVISKHPG | 236 | Q86XA9 | |
| GQDKLLGLVKLPLHQ | 891 | Q4AC94 | |
| NLKQPLLHEGKNGVL | 116 | Q0VF96 | |
| NKSHIITGNKIPLSG | 226 | O00311 | |
| NSGAVLGKTRKNHIP | 186 | Q9UBR1 | |
| LSGISLQKKLQHVPG | 251 | Q5JTY5 | |
| LSGISLQKKLQHVPG | 251 | Q4V339 | |
| LSSLKVKGLVLGPIH | 251 | P08195 | |
| PLHLGKLPTQQVKQL | 76 | Q9Y264 | |
| LVIGAIVKNKNLHSP | 56 | P33032 | |
| TLVKLARGHTNGTKP | 356 | P15848 | |
| GNISIPKSNGLIIKH | 481 | A6NNW6 | |
| NLTHLPKGLLGAQAK | 181 | P40197 | |
| IPHIHKSLIGKKGQQ | 111 | P0C0S5 | |
| PGSKEHVLQINKLTG | 81 | Q86VF2 | |
| LKLHAVVQGLGPTFK | 486 | Q8NFJ9 | |
| GQKLSIPQITTKHSG | 376 | Q00888 | |
| GITQILGKSHGSLKL | 576 | Q68DL7 | |
| GIHPKNIQSLEVIGK | 71 | P02775 | |
| LGKPLVLQAALHGQS | 636 | Q92613 | |
| NTGIGQHILKNPLII | 31 | Q9UNQ2 | |
| GQKLFIPQITTKHSG | 376 | Q16557 | |
| KGGLTPLLLAVHGQK | 196 | Q6S8J7 | |
| ISLLHSPGNIGKLLG | 281 | Q99567 | |
| HLGKQLAGTLLQLGP | 86 | Q6NXP6 | |
| QAKLPSGKLQVHLRG | 361 | Q13505 | |
| LALPKGGNKHLSNLT | 2061 | Q86VV8 | |
| HLVGLTKLNLGKNSL | 171 | Q8TF66 | |
| GKVASLGPIKQHTFL | 346 | Q7L592 | |
| GQHILKNGLSLLKIG | 451 | Q9Y2Z4 | |
| GQKLFIPQITTKHSG | 376 | Q9UQ74 | |
| IQKNRLLGKQTGLTP | 346 | Q9Y227 | |
| LLNKHPGVNVQITGL | 456 | Q7Z443 | |
| KNKHGLTPLLLGVHE | 231 | P0CG39 | |
| ILSNNLLKKLPHGLG | 431 | Q9UQ13 | |
| PTKVVHRQGLLGVQK | 271 | Q5T8A7 | |
| ESKNKHGLTPLLLGV | 266 | P0CG38 | |
| GIVHKDIKPGNLLLT | 171 | Q15831 | |
| GQKLSIPQITTKHSG | 376 | Q13046 | |
| GLLVPALKKVQGQVH | 21 | Q07889 | |
| SGGKLHLTKNGVISL | 506 | Q13972 | |
| HLPLSKLQQGIKSGT | 231 | Q9Y2L1 | |
| TLIGVQNPSLLKGKS | 171 | Q8NFU7 | |
| LKHVNALIAPGQKIG | 1361 | Q09428 | |
| GPKSKVLILRNHGLV | 291 | P35611 | |
| NGGLNLHSPVKRKLE | 211 | Q8N8U2 | |
| QQPKLSGSLKFLGHL | 561 | Q9H9A5 | |
| SGHSLILILGNPKLK | 271 | Q9NYW7 | |
| LALHIKIISGQNFPK | 721 | Q15111 | |
| TLAVQGISGLPLKKQ | 186 | Q2NL82 | |
| RGDKQGLLLLHNKTP | 436 | O00295 | |
| LSGLSKHVQTDPGQK | 321 | Q96MU6 | |
| KVKVGHIGNLKLIIP | 56 | Q96RL7 | |
| TKALVLNGKPGHLQF | 346 | Q8IWA0 | |
| GPSKLVQKHLAGLFN | 321 | Q14997 | |
| YAGNIKTLQKLPHIL | 1011 | Q9BQI6 | |
| GNKLQTLSPSHKGIA | 216 | Q96GY0 | |
| LVPGKIQHILCTGNL | 26 | Q9UBQ0 | |
| LQSLPGKQLPSHKAI | 136 | Q9NQH7 | |
| KNGIPLESNHTIKAG | 366 | P35968 | |
| PAKLHNSLIGTKGRL | 661 | Q00341 | |
| ANLTGSHKLKPLVIG | 281 | Q53EQ6 | |
| ESKNKHGLTPLLLGV | 266 | Q6S5H5 | |
| ESKNKHGLTPLLLGV | 266 | A6NI47 | |
| KNLATVGGQIIKPSL | 76 | Q9BUY5 | |
| VLTGLQSGQPKHLLL | 521 | P29353 | |
| LLHIFTVNKQLGPKI | 906 | Q8TD43 | |
| KKQLSHLNVINDGGP | 926 | Q9P1Q0 |